Clinical Trial Update: Efficacy and Safety of Lobeglitazone Versus Sitagliptin [Phase 4]

View source ↗

Summary

This Phase 4 trial update compares the efficacy and safety of lobeglitazone versus sitagliptin in adults with type 2 diabetes, reporting on comparative outcomes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lobeglitazone (lobeglitazone)
• Sitagliptin (sitagliptin)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: UNKNOWN